NovaBay Jumps on Amazon Pact
NovaBay Pharmaceuticals, Inc. (NYSE:NBY) rose sharply Tuesday after rising around 875% Monday after the company reached an agreement to sell its eye care product on Amazon.com. The Emeryville, Calif-based NovaBay, a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that Avenova® Direct is available at affordable pricing […]